<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> is caused by a combination of <z:hpo ids='HP_0006279'>beta-cell dysfunction</z:hpo> and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Over time, <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> worsens, a phenomenon that has been attributed to deleterious effects of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> (glucotoxicity) or <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0003077'>hyperlipidemia</z:hpo> (lipotoxicity) on beta-cell function and is often accompanied by increased islet triacylglycerol (TAG) content and decreased insulin gene expression </plain></SENT>
<SENT sid="2" pm="."><plain>To examine these two potentially pathogenic forces, we studied <z:chebi fb="3" ids="16646">Zucker</z:chebi> rats (leptin receptor <z:mp ids='MP_0002169'>wild type</z:mp>, +/+; heterozygous, +/-; and mutant, -/-) </plain></SENT>
<SENT sid="3" pm="."><plain>First, +/+ and +/- <z:chebi fb="3" ids="16646">Zucker</z:chebi> rats were compared metabolically </plain></SENT>
<SENT sid="4" pm="."><plain>At 6 weeks of age, the +/- rats had a lower level of islet insulin <z:chebi fb="2" ids="33699">mRNA</z:chebi> compared with +/+ </plain></SENT>
<SENT sid="5" pm="."><plain>At 12 weeks of age, differences were found in body weight and islet TAG content; however, levels of insulin <z:chebi fb="2" ids="33699">mRNA</z:chebi> were equivalent </plain></SENT>
<SENT sid="6" pm="."><plain>Second, we examined whether worsening of the diabetic state in the homozygous mutant (-/-) <z:chebi fb="3" ids="16646">Zucker</z:chebi> diabetic fatty (ZDF) rat is related more to <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> or to <z:hpo ids='HP_0003077'>hyperlipidemia</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>The ZDF rats were treated for 6 weeks with either <z:chebi fb="0" ids="47612">bezafibrate</z:chebi>, a <z:chebi fb="23" ids="18059">lipid</z:chebi>-lowering drug that does not affect plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> levels, or <z:chebi fb="0" ids="8113">phlorizin</z:chebi>, a drug that reduces plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> without lowering <z:chebi fb="23" ids="18059">lipid</z:chebi> levels </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="0" ids="47612">Bezafibrate</z:chebi> treatment lessened the rise in plasma TAG observed in nontreated rats (239 +/- 16 vs. 388 +/- 36 mg/dl, treated versus nontreated; P &lt; 0.0001) but did not prevent the rise in fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> </plain></SENT>
<SENT sid="9" pm="."><plain>Despite lowering plasma TAG, <z:chebi fb="0" ids="47612">bezafibrate</z:chebi> was not effective in preventing an increased islet TAG content and did not prevent the associated decrease in insulin <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels </plain></SENT>
<SENT sid="10" pm="."><plain><z:chebi fb="0" ids="8113">Phlorizin</z:chebi> treatment prevented <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> (61 +/- 2 vs. 145 +/- 7 mg/dl, treated versus nontreated; P &lt; 0.0001) and lowered islet TAG content (32.7 +/- 0.7 vs. 47.8 +/- 2.7 ng/islet, treated versus nontreated; P &lt; 0.0001) and preserved insulin <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels without preventing <z:hpo ids='HP_0002155'>hypertriglyceridemia</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>Plasma free fatty acid level did not correlate with changes in islet TAG or insulin <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels </plain></SENT>
<SENT sid="12" pm="."><plain>We conclude that antecedent elevated plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> levels, not plasma <z:chebi fb="23" ids="18059">lipid</z:chebi> levels, are associated with elevated islet TAG content and decreased insulin <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels in ZDF animals </plain></SENT>
</text></document>